Equibles does not estimate personal net worth.
Get an email with a short summary when Tenaya Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TNYA alertsFaraz Ali is recorded as CFO at Tenaya Therapeutics, Inc. (TNYA) since August 14, 2024, Board Member at Tenaya Therapeutics, Inc. (TNYA) since January 1, 2018 and CEO at Tenaya Therapeutics, Inc. (TNYA). The newest filing on record that lists Faraz Ali as CEO and Board Member at Tenaya Therapeutics, Inc. (TNYA) is dated April 16, 2026. Tenaya Therapeutics, Inc. reported in an 8-K filed August 8, 2024 that Faraz Ali was appointed Interim Principal Financial Officer, effective August 14, 2024. The proxy statement of Tenaya Therapeutics, Inc. reports total compensation of $1,881,396 for Faraz Ali in fiscal 2025, including a base salary of $664,173. Disclosed compensation is on record for 6 fiscal years. Faraz Ali has spoken on 1 investor event across 1 company, most recently for Tenaya Therapeutics, Inc. on June 4, 2026. Tenaya Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Tenaya Therapeutics, Inc. includes Eric Hyllengren (CFO), Chihiro Saito (Chief Accounting Officer), Tomohiro Higa (Chief Accounting Officer) and 7 others.
“Faraz Ali, Chief Executive Officer of Tenaya, will become Interim PFO in addition to his role as Chief Executive Officer.”
“Thanks, and thanks to the Jefferies team for inviting us and giving us this opportunity to tell you a little bit more about Tenaya Therapeutics. We're a publicly traded company.”
2024-08-14–present
2018-01-01–present
Last confirmed April 16, 2026
Start not stated–present
Last confirmed April 16, 2026
Biotechnology · Healthcare
CEO, CFO, Board Member
2018-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Tenaya Therapeutics, Inc. (TNYA) | M.B.A. Chief Executive Officer | $664,173 | $1,881,396 |
| 2024 | Tenaya Therapeutics, Inc. (TNYA) | M.B.A. | $636,189 | $3,281,901 |
| 2023 | Tenaya Therapeutics, Inc. (TNYA) | M.B.A. | $593,800 | $2,890,062 |
| 2022 | Tenaya Therapeutics, Inc. (TNYA) | M.B.A. | $571,459 | $5,567,400 |
| 2021 | Tenaya Therapeutics, Inc. (TNYA) | M.B.A. | $493,750 | $4,970,756 |
| 2020 | Tenaya Therapeutics, Inc. (TNYA) | M.B.A. | $425,000 | $750,300 |
